Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification of HER-2/neu immunogenic epitopes presented by renal cell carcinoma and other human epithelial tumors.
Scardino A, Alves P, Gross DA, Tourdot S, Graff-Dubois S, Angevin E, Firat H, Chouaib S, Lemonnier F, Nadler LM, Cardoso AA, Kosmatopoulos K. Scardino A, et al. Among authors: kosmatopoulos k. Eur J Immunol. 2001 Nov;31(11):3261-70. doi: 10.1002/1521-4141(200111)31:11<3261::aid-immu3261>3.0.co;2-4. Eur J Immunol. 2001. PMID: 11745343 Free article.
High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy.
Gross DA, Graff-Dubois S, Opolon P, Cornet S, Alves P, Bennaceur-Griscelli A, Faure O, Guillaume P, Firat H, Chouaib S, Lemonnier FA, Davoust J, Miconnet I, Vonderheide RH, Kosmatopoulos K. Gross DA, et al. Among authors: kosmatopoulos k. J Clin Invest. 2004 Feb;113(3):425-33. doi: 10.1172/JCI19418. J Clin Invest. 2004. PMID: 14755339 Free PMC article.
STEAP, a prostate tumor antigen, is a target of human CD8+ T cells.
Alves PM, Faure O, Graff-Dubois S, Cornet S, Bolonakis I, Gross DA, Miconnet I, Chouaib S, Fizazi K, Soria JC, Lemonnier FA, Kosmatopoulos K. Alves PM, et al. Among authors: kosmatopoulos k. Cancer Immunol Immunother. 2006 Dec;55(12):1515-23. doi: 10.1007/s00262-006-0165-3. Epub 2006 Apr 19. Cancer Immunol Immunother. 2006. PMID: 16622681 Free PMC article.
H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies.
Firat H, Garcia-Pons F, Tourdot S, Pascolo S, Scardino A, Garcia Z, Michel ML, Jack RW, Jung G, Kosmatopoulos K, Mateo L, Suhrbier A, Lemonnier FA, Langlade-Demoyen P. Firat H, et al. Among authors: kosmatopoulos k. Eur J Immunol. 1999 Oct;29(10):3112-21. doi: 10.1002/(SICI)1521-4141(199910)29:10<3112::AID-IMMU3112>3.0.CO;2-Q. Eur J Immunol. 1999. PMID: 10540322 Free article.
A general strategy to enhance immunogenicity of low-affinity HLA-A2. 1-associated peptides: implication in the identification of cryptic tumor epitopes.
Tourdot S, Scardino A, Saloustrou E, Gross DA, Pascolo S, Cordopatis P, Lemonnier FA, Kosmatopoulos K. Tourdot S, et al. Among authors: kosmatopoulos k. Eur J Immunol. 2000 Dec;30(12):3411-21. doi: 10.1002/1521-4141(2000012)30:12<3411::AID-IMMU3411>3.0.CO;2-R. Eur J Immunol. 2000. PMID: 11093159 Free article.
Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A*0201 transgenic, H-2 class I KO mice.
Firat H, Tourdot S, Ureta-Vidal A, Scardino A, Suhrbier A, Buseyne F, Rivìere Y, Danos O, Michel ML, Kosmatopoulos K, Lemonnier FA. Firat H, et al. Among authors: kosmatopoulos k. Eur J Immunol. 2001 Oct;31(10):3064-74. doi: 10.1002/1521-4141(2001010)31:10<3064::aid-immu3064>3.0.co;2-l. Eur J Immunol. 2001. PMID: 11592083 Free article.
59 results